Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1994-11-03
1998-09-22
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
514573, A61K 9127, A61K 9133
Patent
active
058111182
ABSTRACT:
This invention provides a method of administering an arachidonic acid metabolite, such as prostaglandin E1, to an animal. The metabolite is given to the animal, typically a human, in association with a unilamellar liposome comprising a lipid and a release-inhibiting aqueous buffer. This method can be used to treat animals afflicted with disorders characterized by cell activation and adhesion, inflammation or toxemia.
REFERENCES:
patent: 4493847 (1985-01-01), Mizushima et al.
patent: 4684633 (1987-08-01), Imagawa et al.
patent: 4820732 (1989-04-01), Shell et al.
patent: 4880635 (1989-11-01), Janoff
patent: 4955878 (1990-09-01), See et al.
patent: 5077056 (1991-12-01), Bally et al.
patent: 5082664 (1992-01-01), Lenk
patent: 5262168 (1993-11-01), Lenk
Mizushime, J. Rheumatology 14, p. 97, 1987.
Gilman, et al., ed., Goodman and Gilmans's "The Pharacological Basis of Therapeutics", Eighth Edition, Pergamon Press, New York, 600-611 (1990).
Hoshi, et al., (Drug. Exptl. Clin. Res. 12(8), 681, 1986.
Jugdutt, et al., "Dissimilar Effects of Prostacyclin, Prostaglandin E1, and Prostaglandin E2 on Myocardial Infarct Size after Coronary Occlusion in Conscious Dogs", Circulation Research, vol. 49, No. 3, pp. 685-700 (1981).
Mizushima, et al., "A Multicenter Double Blind Controlled Study of Lipo-PGE.sub.1, PGE1 Incorporated in Lipid Microspheres, in Peripheral Vascular Disease Secondary to Connective Tissue Disorder", J. Rheumatol. 14:97-101 (1987).
Bone, et al., "Randomized Double-Blind, Multicenter Study of Prostaglandin E1 in Patients with the Adult Respiratory Distress Syndrome", Chest, 96(1):114-119, Jul. 1989.
Janoff Andrew S.
Minchey Sharma R.
Ostro Marc J.
Goodman Rosanne
Kishore Gollamudi S.
Rubin Kenneth B.
The Liposome Company Inc.
LandOfFree
Methods of treatment using unilamellar liposomal arachidonic aci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment using unilamellar liposomal arachidonic aci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using unilamellar liposomal arachidonic aci will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1620261